Determining whether Synthomer is a suitable purchase depends heavily on an investor's tolerance for turnaround risk, cyclical industrial exposure, and volatile balance sheet metrics. While optimistic investors point to aggressive debt reduction, asset divestments, and improving operational guidance as catalysts for substantial recovery, conservative investors often view the equity as speculative until the company demonstrates consistent, long-term net profitability and stronger cash generation.